Paper by CBI researchers helps define challenges with scaling of vaccine manufacturing

person with syringe

The team, led by CBI research scientist Donovan Guttieres published ‘Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2’ in the March 2021 volume of Antibody Therapeutics.

This work was funded by the MIT-IBM Watson AI Lab and was previously featured in MIT news.

Read the paper

Read the MIT News article